Japan Issues Draft Guidance On Microdosing
This article was originally published in PharmAsia News
Executive Summary
Japan's Ministry of Health, Labor and Welfare has issued a draft guidance on microdosing in an effort to encourage companies to make quicker development decisions related to early stage compounds. The draft guidance defines a microdose as a single dose of less than 1/100th of a dose of a test substance calculated to yield a pharmacologic effect, with a maximum dose of no more than100µgs. Microdosing has been implemented in both the U.S. and European Union; the draft guidance is the first such measure in Japan. The draft guidance is expected to be implemented in Japan as early as March; MHLW is accepting comments on the document until Feb. 8. (Click here for more.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.